StockDuty ← Dashboard Sep 26, 2026 02:33 AM ET
SignalFDA/Bio

Novartis (NVS) and Bristol Myers (BMY) Pause Autoimmune CAR-T Studies. Can Their Programs Recover?

Novartis and Bristol Myers paused autoimmune CAR-T studies, raising program recovery concerns.

What changed
Novartis and Bristol Myers paused autoimmune CAR-T studies, raising program recovery concerns.
Why it matters
Novartis and Bristol Myers paused autoimmune CAR-T studies, raising program recovery concerns. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →